1. Therapeutic potency of Wnt signaling antagonists in the pathogenesis of prostate cancer, current status and perspectives
   Mehran Pashirzad et al, 2019, Journal of Cellular Physiology CrossRef
2. Neutralizing monoclonal antibody against Dickkopf2 impairs lung cancer progression via activating NK cells
   Tianli Shen et al, 2019, Cell Death Discovery CrossRef
3. A Genomic-clinicopathologic Nomogram for the Preoperative Prediction of Lymph Node Metastasis in Bladder Cancer
   Shao-Xu Wu et al, 2018, EBioMedicine CrossRef
4. Echogenic, Ultrasound-Sensitive Chitosan Nanodroplets for Spatiotemporally Controlled DKK-2 Gene Delivery to Prostate Cancer Cells
   Xinxin Liu et al, 2021, International Journal of Nanomedicine CrossRef
5. A comprehensive meta-analysis and a case–control study give insights into genetic susceptibility of lung cancer and subgroups
   Debmalya Sengupta et al, 2021, Scientific Reports CrossRef
6. Luteolin suppresses gastric cancer progression by reversing epithelial-mesenchymal transition via suppression of the Notch signaling pathway
   Ming-de Zang et al, 2017, Journal of Translational Medicine CrossRef
7. The Role of the Wnt Pathway in VEGF/Anti-VEGF-Dependent Control of the Endothelial Cell Barrier
   Yueru Li et al, 2021, Investigative Opthalmology & Visual Science CrossRef
8. Exploring the Wnt Pathway as a Therapeutic Target for Prostate Cancer
   Sarah Koushyar et al, 2022, Biomolecules CrossRef
9. Comparative Pathobiology of Canine and Human Prostate Cancer: State of the Art and Future Directions
   Eduardo de Paula Nascente et al, 2022, Cancers CrossRef
10. Androgen/Wnt/β‐catenin signal axis augments cell proliferation of the mouse erectile tissue, corpus cavernosum
    Mizuki Kajimoto et al, 2022, Congenital Anomalies CrossRef
11. CircCNIH4 inhibits gastric cancer progression via regulating DKK2 and FRZB expression and Wnt/β-catenin pathway
    Qi Shi et al, 2021, Journal of Biological Research-Thessaloniki CrossRef